(Q48201487)

9 February 2018

title

Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency (English)

1 reference

9 February 2018

author

Richard Wiese

3

1 reference

9 February 2018

Sören Krach

6

object named as

Sören Krach

1 reference

9 February 2018

André Kirner-Veselinovic

2

object named as

André Kirner-Veselinovic

0 references

Tilo T. Kircher

object named as

Tilo Kircher

5

0 references

author name string

Arne Nagels

1

1 reference

9 February 2018

André Kirner-Veselinovic

2

1 reference

9 February 2018

Frieder M Paulus

4

1 reference

9 February 2018

publication date

22 December 2011

1 reference

9 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

9 February 2018

volume

262

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

403-414

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00406-011-0281-8

exact match

0 references

cites work

Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The NMDA antagonist model for schizophrenia: promise and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Mouse behavioral endophenotypes for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Scale for the assessment of thought, language, and communication (TLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Organization of cognitive control within the lateral prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The representation of abstract task rules in the human prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The role of frontopolar cortex in subgoal processing during working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Does ketamine mimic aspects of schizophrenic speech?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Phencyclidine disturbs relational memory in the transitive inference task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Differential activation of temporal cortex during sentence completion in schizophrenic patients with and without formal thought disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

[Neural correlates of "negative" formal thought disorder].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Neural correlates of rhyming vs. lexical and semantic fluency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Neural correlates of metaphor processing in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Comparison of hemispheric activation during mental word and rhyme generation using transcranial Doppler sonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The neural correlates of ego-disturbances (passivity phenomena) and formal thought disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The assessment and analysis of handedness: The Edinburgh inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Selective cognitive impairments associated with NMDA receptor blockade in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

A systems model of altered consciousness: integrating natural and drug-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

Effects of Psychotic State and Task Demand on Prefrontal Function in Schizophrenia: An fMRI Study of Overt Verbal Fluency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0281-8

The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers.

21 January 2018

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

12 December 2020

Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception

1 reference

12 December 2020

Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes

1 reference

12 December 2020

Glutamate pharmacology and the treatment of schizophrenia: current status and future directions

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors

1 reference

12 December 2020

10.1007/S00406-011-0281-8

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018